Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavopiridol in Metastatic Androgen Independent Prostate Cancer
NCT00003256Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 1998
- Primary completion
- Jul 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alvocidib in prostate cancer (PCa), sponsored by National Cancer Institute. Started May 1998; status: completed.
02
Drugs
alvocidib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003256.